Netazepide, a Gastrin Receptor Antagonist, Normalises Tumour Biomarkers and Causes Regression of Type 1 Gastric Neuroendocrine Tumours in a Nonrandomised Trial of Patients with Chronic Atrophic Gastritis

Andrew R. Moore(University of Liverpool), D. Mark Pritchard(University of Liverpool)
PLoS ONE
October 1, 2013
10.1371/journal.pone.0076462
Cited by 62

Related Papers

Comparison of the human gastric microbiota in hypochlorhydric states arising as a result of Helicobacter pylori-induced atrophic gastritis, autoimmune atrophic gastritis and proton pump inhibitor use
|PLoS Pathogens|2017|203
Gastric Helicobacter Infection Induces Iron Deficiency in the INS-GAS Mouse
|PLoS ONE|2012|36
Signaling mediated by the NF-κB sub-units NF-κB1, NF-κB2 and c-Rel differentially regulate Helicobacter felis-induced gastric carcinogenesis in C57BL/6 mice
|Oncogene|2013|36
Correction: Netazepide, a Gastrin Receptor Antagonist, Normalises Tumour Biomarkers and Causes Regression of Type 1 Gastric Neuroendocrine Tumours in a Nonrandomised Trial of Patients with Chronic Atrophic Gastritis
|PLoS ONE|2013|8
* Host iron metabolism gene expression in ins-gas mouse model of helicobacter infection
|Gut|2011|0